Anti-Hu CD262 PE

*Artykov AA, Yagolovich AV, Dolgikh DA, Kirpichnikov MP, Trushina DB, Gasparian ME: Death receptors DR4 and DR5 undergo spontaneous and ligand-mediated endocytosis and recycling regardless of the sensitivity of cancer cells to TRAIL. Front Cell Dev Biol. 2021 Sep 30;9:733688., URL: https://pubmed.ncbi.nlm.nih.gov/34660590/, *Masum AA, Hisamatsu Y, Yokoi K, Aoki S: Luminescent iridium complex-peptide hybrids (IPHs) for therapeutics of cancer: design and synthesis of IPHs for detection of cancer cells and induction of their necrosis-type cell death. Bioinorg Chem Appl. 2018 Aug 1;2018:7578965., URL: https://pubmed.ncbi.nlm.nih.gov/30154833/

*Corallini F, Milani D, Nicolin V, Secchiero P: TRAIL, caspases and maturation of normal and leukemic myeloid precursors. Leuk Lymphoma. 2006 Aug;47 (8) :1459-68., URL: https://www.ncbi.nlm.nih.gov/pubmed/16966254?dopt=